Genestac
Our Services

CD56 Enrichment: Advancing NK Cell Isolation & Immunotherapy

Clinical-Grade NK Cell Isolation for Cancer & Viral Immunity

Using CD56 (NCAM) as a surface marker to isolate highly cytotoxic Natural Killer cells โ€” powering tumor-targeting immunotherapy, HSCT support, and neurobiology research.

WhatsApp Us
What is CD56 Enrichment?

CD56 Enrichment is a process that isolates NK cells (Natural Killer cells) using CD56, also known as Neural Cell Adhesion Molecule (NCAM). This surface marker is highly expressed on NK cells and subsets of T cells, playing a vital role in immune defense, cell-to-cell interactions, and migration. CD56 Enrichment is essential in NK cell isolation, cancer immunotherapy, and immunology research.

TUMOR CELLCD56+ NK CELLCD56 (NCAM)
Cell Classification

CD56+ Cell Subtypes

CD56แต‡สณแดตแดณสฐแต— NK Cells

Immature, cytokine-producing cells with immunoregulatory functions. Found primarily in lymph nodes.

CD56แตˆแดตแต NK Cells

Highly cytotoxic, efficient in targeting tumor or virally infected cells. The primary cytotoxic subset in peripheral blood.

CD3โป CD56โบ NK Cells

Standard phenotype for adoptive NK cell therapy โ€” no T cell receptor, pure NK cytotoxicity.

Clinical Use

Applications of CD56 Enrichment in NK Cell Isolation

1

Cancer Immunotherapy

Enriched NK cells are used for tumor-targeting immunotherapy without prior sensitization.

2

Stem Cell Transplantation

CD56 Enrichment helps improve outcomes and reduce GVHD in HSCT.

3

Viral Immunity

NK cells enriched via CD56 play a key role against HIV, hepatitis, and influenza.

4

Neurobiology Research

CD56 is expressed in neural tissues, aiding stem cell and neuroscience studies.

Our Expertise

Genestac's CD56 Enrichment Services

At Genestac Therapeutics, we provide clinical-grade CD56 Enrichment and NK cell isolation using advanced MACS and FACS technologies. Our services include:

1

High Purity & Viability of NK Cells

Delivering >90% CD56+ cells with high post-isolation viability, verified by flow cytometry.

2

Scalable Enrichment

Flexible protocols from research-scale to clinical-grade volumes for both autologous and allogeneic applications.

3

Custom CD56bright & CD56dim Isolation

Subtype-specific enrichment for cytokine studies (bright) or cytotoxicity assays (dim).

Comparison

CD56bright vs. CD56dim NK Cells

FeatureCD56bright NK CellsCD56dim NK Cells
FunctionImmunoregulatoryCytotoxic
LocationLymph nodesPeripheral blood
Cytokine ProductionHighLow
Conclusion

CD56 Enrichment is a cornerstone for NK cell immunotherapy, cancer research, and stem cell applications. With Genestac Therapeutics' precision isolation methods, researchers and clinicians gain access to highly purified NK cell populations that accelerate discoveries and therapeutic outcomes.

FAQs about CD56 Enrichment

Frequently Asked Questions

Is CD56 only found on NK cells?

No. While CD56 is a primary marker for NK cells, it is also expressed on a subset of T cells (NKT cells), some dendritic cells, neuroendocrine cells, and neural tissue. In hematological contexts, however, CD56 is predominantly used to identify and isolate NK cells from peripheral blood or bone marrow.

What are the benefits of CD56 Enrichment?

CD56 Enrichment provides highly purified NK cell populations with excellent viability. This enables more accurate cytotoxicity assays, consistent immunotherapy product manufacturing, reduced non-specific immune activity in transplant settings (lowering GVHD risk), and scalable research applications.

How does CD56 Enrichment support cancer immunotherapy?

CD56-enriched NK cells are used in adoptive cell transfer therapies where they are infused into patients to target and kill tumor cells without requiring prior sensitization. CD56dim NK cells are especially cytotoxic against hematologic cancers, and CD56bright cells contribute immunoregulatory cytokines that shape the anti-tumor immune environment.

Does Genestac provide custom NK cell isolation?

Yes. Genestac Therapeutics offers fully customized CD56 enrichment protocols, including subtype-specific isolation (CD56bright vs CD56dim), depletion of CD3+ T cells for purer NK products, and downstream activation or expansion services โ€” all under GMP-compliant conditions with full QC reporting.

Start Your Healing Journey Today

Access premium CD56 NK cell enrichment services tailored for your clinical or research pipeline.

โ† Back to Home

Genestac Assistant

Always Online

Hi! ๐Ÿ‘‹ I'm here to help you. What is your name?
Support Doctor